BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24144008)

  • 1. Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.
    Zhang G; Qu Y; Dang S; Yang Q; Shi B; Hou P
    Diagn Pathol; 2013 Oct; 8():173. PubMed ID: 24144008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients.
    Dang S; Qu Y; Wei J; Shao Y; Yang Q; Ji M; Shi B; Hou P
    Diagn Pathol; 2014 Feb; 9():28. PubMed ID: 24499477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mitochondrial DNA copy number associated with clinical characteristics and prognosis in gastric cancer?
    Lee H; Lee JH; Kim DC; Hwang I; Kang YN; Gwon GJ; Choi IJ; Kim S
    Asian Pac J Cancer Prev; 2015; 16(1):87-90. PubMed ID: 25640396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study.
    Liao LM; Baccarelli A; Shu XO; Gao YT; Ji BT; Yang G; Li HL; Hoxha M; Dioni L; Rothman N; Zheng W; Chow WH
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1944-9. PubMed ID: 21784958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression and clinical significance of miR-132 in gastric cancer patients.
    Liu X; Yu H; Cai H; Wang Y
    Diagn Pathol; 2014 Mar; 9():57. PubMed ID: 24621117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma.
    Chang TC; Lee HT; Pan SC; Cho SH; Cheng C; Ou LH; Lin CI; Lin CS; Wei YH
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are PIK3CA Mutation and Amplification Associated with Clinicopathological Characteristics of Gastric Cancer?
    Lee H; Hwang IS; Choi IJ; Kang YN; Park KU; Lee JH
    Asian Pac J Cancer Prev; 2015; 16(11):4493-6. PubMed ID: 26107192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAR expression and copy number variation in patients with advanced gastric cancer.
    Behroozi J; Shahbazi S; Bakhtiarizadeh MR; Mahmoodzadeh H
    BMC Gastroenterol; 2020 May; 20(1):152. PubMed ID: 32410589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
    Jin J; Jin T; Quan M; Piao Y; Lin Z
    Diagn Pathol; 2012 Oct; 7():135. PubMed ID: 23039327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
    Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood mitochondrial DNA copy number is associated with prostate cancer risk and tumor burden.
    Zhou W; Zhu M; Gui M; Huang L; Long Z; Wang L; Chen H; Yin Y; Jiang X; Dai Y; Tang Y; He L; Zhong K
    PLoS One; 2014; 9(10):e109470. PubMed ID: 25279731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer.
    Liu X; Xiong H; Li J; He Y; Yuan X
    Diagn Pathol; 2013 Apr; 8():62. PubMed ID: 23587030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.
    Gao C; Ma T; Pang L; Xie R
    Diagn Pathol; 2014 Mar; 9():55. PubMed ID: 24621074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patients.
    Zhang Y; Qu Y; Gao K; Yang Q; Shi B; Hou P; Ji M
    Am J Cancer Res; 2015; 5(3):1207-16. PubMed ID: 26045999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer.
    Xu H; He W; Jiang HG; Zhao H; Peng XH; Wei YH; Wei JN; Xie CH; Liang C; Zhong YH; Zhang G; Deng D; Zhou YF; Zhou FX
    Oncol Rep; 2013 Dec; 30(6):3006-12. PubMed ID: 24101028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of decreased mitochondrial DNA content with the progression of colorectal cancer.
    Cui H; Huang P; Wang Z; Zhang Y; Zhang Z; Xu W; Wang X; Han Y; Guo X
    BMC Cancer; 2013 Mar; 13():110. PubMed ID: 23497023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.
    Weerts MJ; Sieuwerts AM; Smid M; Look MP; Foekens JA; Sleijfer S; Martens JW
    Oncotarget; 2016 May; 7(20):29166-76. PubMed ID: 27081694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.